An innovative three-dimensional gelatin foam culture system for improved study of glioblastoma stem cell behavior
Meng-Yin Yang
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Department of Physical Therapy, Hungkuang University, Taichung, Taiwan
Department of Neurological Surgery, Jan-Ai General Hospital, Taichung, Taiwan
Search for more papers by this authorMing-Tsang Chiao
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Search for more papers by this authorHsu-Tung Lee
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Search for more papers by this authorChien-Min Chen
Division of Neurological Surgery, Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan
Search for more papers by this authorYi-Chin Yang
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Search for more papers by this authorCorresponding Author
Chiung-Chyi Shen
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Department of Physical Therapy, Hungkuang University, Taichung, Taiwan
Department of Medicine, National Defense Medical Center, Taipei, Taiwan
Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Correspondence to: Dr. C.-C. Shen (e-mail: [email protected]) and Dr. H.-I. Ma (e-mail: [email protected])Search for more papers by this authorCorresponding Author
Hsin-I. Ma
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Correspondence to: Dr. C.-C. Shen (e-mail: [email protected]) and Dr. H.-I. Ma (e-mail: [email protected])Search for more papers by this authorMeng-Yin Yang
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Department of Physical Therapy, Hungkuang University, Taichung, Taiwan
Department of Neurological Surgery, Jan-Ai General Hospital, Taichung, Taiwan
Search for more papers by this authorMing-Tsang Chiao
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Search for more papers by this authorHsu-Tung Lee
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Search for more papers by this authorChien-Min Chen
Division of Neurological Surgery, Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan
Search for more papers by this authorYi-Chin Yang
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Search for more papers by this authorCorresponding Author
Chiung-Chyi Shen
Department of Minimally Invasive Skull Neurosurgery, Neurological Institute, Taichung Veterans General Hospital, Taichung, Taiwan
Department of Physical Therapy, Hungkuang University, Taichung, Taiwan
Department of Medicine, National Defense Medical Center, Taipei, Taiwan
Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Correspondence to: Dr. C.-C. Shen (e-mail: [email protected]) and Dr. H.-I. Ma (e-mail: [email protected])Search for more papers by this authorCorresponding Author
Hsin-I. Ma
Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei, Taiwan
Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan
Correspondence to: Dr. C.-C. Shen (e-mail: [email protected]) and Dr. H.-I. Ma (e-mail: [email protected])Search for more papers by this authorAbstract
Three-dimensional (3-D) tissue engineered constructs provide a platform for examining how the local extracellular matrix contributes to the malignancy of various cancers, including human glioblastoma multiforme. Here, we describe a simple and innovative 3-D culture environment and assess its potential for use with glioblastoma stem cells (GSCs) to examine the diversification inside the cell mass in the 3-D culture system. The dissociated human GSCs were cultured using gelatin foam. These cells were subsequently identified by immunohistochemical staining, reverse transcriptase-polymerase chain reaction, and Western blot assay. We demonstrate that the gelatin foam provides a suitable microenvironment, as a 3-D culture system, for GSCs to maintain their stemness. The gelatin foam culture system contributes a simplified assessment of cell blocks for immunohistochemistry assay. We show that the significant transcription activity of hypoxia and the protein expression of inflammatory responses are detected at the inside of the cell mass in vitro, while robust expression of PROM1/CD133 and hypoxia-induced factor-1 alpha are detected at the xenografted tumor in vivo. We also examine the common clinical trials under this culture platform and characterized a significant difference of drug resistance. The 3-D gelatin foam culture system can provide a more realistic microenvironment through which to study the in vivo behavior of GSCs to evaluate the role that biophysical factors play in the hypoxia, inflammatory responses and subsequent drug resistance. © 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 618–628, 2015.
REFERENCES
- 1 Parent CA, Devreotes PN. A cell's sense of direction. Science 1999; 284: 765–770.
- 2 Campbell JJ, Butcher EC. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing. Curr Opin Immunol 2000; 12: 336–341.
- 3 Paszek MJ, Zahir N, Johnson KR, Lakins JN, Rozenberg GI, Gefen A, Reinhart-King CA, Margulies SS, Dembo M, Boettiger D, Hammer DA, Weaver VM. Tensional homeostasis and the malignant phenotype. Cancer Cell 2005; 8: 241–254.
- 4 Lauffenburger DA, Horwitz AF. Cell migration: A physically integrated molecular process. Cell 1996; 84: 359–369.
- 5 Loessner D, Stok KS, Lutolf MP, Hutmacher DW, Clements JA, Rizzi SC. Bioengineered 3d platform to explore cell–ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 2010; 31: 8494–8506.
- 6 Yamada KM, Cukierman E. Modeling tissue morphogenesis and cancer in 3d. Cell 2007; 130: 601–610.
- 7 Chabner BA, Roberts TG Jr. Timeline: Chemotherapy and the war on cancer. Nat Rev Cancer 2005; 5: 65–72.
- 8 Lindhagen E, Nygren P, Larsson R. The fluorometric microculture cytotoxicity assay. Nat Protoc 2008; 3: 1364–1369.
- 9 Blumenthal RD. An overview of chemosensitivity testing. Methods Mol Med 2005; 110: 3–18.
- 10 Kunz-Schughart LA, Freyer JP, Hofstaedter F, Ebner R. The use of 3-d cultures for high-throughput screening: The multicellular spheroid model. J Biomol Screen 2004; 9: 273–285.
- 11 Kim JB, Stein R, O'Hare MJ. Three-dimensional in vitro tissue culture models of breast cancer—A review. Breast Cancer Res Treat 2004; 85: 281–291.
- 12 Zhao F, Grayson WL, Ma T, Bunnell B, Lu WW. Effects of hydroxyapatite in 3-d chitosan–gelatin polymer network on human mesenchymal stem cell construct development. Biomaterials 2006; 27: 1859–1867.
- 13 Chen X, Xu H, Wan C, McCaigue M, Li G. Bioreactor expansion of human adult bone marrow-derived mesenchymal stem cells. Stem Cells 2006; 24: 2052–2059.
- 14 Baker EL, Bonnecaze RT, Zaman MH. Extracellular matrix stiffness and architecture govern intracellular rheology in cancer. Biophys J 2009; 97: 1013–1021.
- 15 Szot CS, Buchanan CF, Freeman JW, Rylander MN. 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 2011; 32: 7905–7912.
- 16 Chiao MT, Yang YC, Cheng WY, Shen CC, Ko JL. Cd133+ glioblastoma stem-like cells induce vascular mimicry in vivo. Curr Neurovasc Res 2011; 8: 210–219.
- 17 Chiao MT, Cheng WY, Yang YC, Shen CC, Ko JL. Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells. Autophagy 2013; 9: 1509–1526.
- 18 Di Stefano V, Rinaldo C, Sacchi A, Soddu S, D'Orazi G. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis. Exp Cell Res 2004; 293: 311–320.
- 19 Ma L, Zhou C, Lin B, Li W. A porous 3d cell culture micro device for cell migration study. Biomed Microdevices 2010; 12: 753–760.
- 20 Fischbach C, Chen R, Matsumoto T, Schmelzle T, Brugge JS, Polverini PJ, Mooney DJ. Engineering tumors with 3d scaffolds. Nat Methods 2007; 4: 855–860.
- 21 Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, van der Wall E. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 2001; 93: 309–314.
- 22 Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006; 66: 605–612.
- 23 Leek RD, Harris AL. Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 2002; 7: 177–189.
- 24 Harley BA, Kim HD, Zaman MH, Yannas IV, Lauffenburger DA, Gibson LJ. Microarchitecture of three-dimensional scaffolds influences cell migration behavior via junction interactions. Biophys J 2008; 95: 4013–4024.
- 25 Levental KR, Yu H, Kass L, Lakins JN, Egeblad M, Erler JT, Fong SF, Csiszar K, Giaccia A, Weninger W, Yamauchi M, Gasser DL, Weaver VM. Matrix crosslinking forces tumor progression by enhancing integrin signaling. Cell 2009; 139: 891–906.
- 26 Baker EL, Zaman MH. The biomechanical integrin. J Biomech 2010; 43: 38–44.
- 27 Griffith LG, Swartz MA. Capturing complex 3d tissue physiology in vitro. Nat Rev Mol Cell Biol 2006; 7: 211–224.
- 28 Mayall FG, Wood I. Gelatin foam cell blocks made from cytology fluid specimens. J Clin Pathol 2011; 64: 818–819.
- 29 Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia and cancer. J Mol Med (Berl) 2007; 85: 1301–1307.
- 30 Yang L, Lin C, Wang L, Guo H, Wang X. Hypoxia and hypoxia-inducible factors in glioblastoma multiforme progression and therapeutic implications. Exp Cell Res 2012; 318: 2417–2426.
- 31 Hardee ME, Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol 2012; 181: 1126–1141.
- 32 Fujiwara S, Nakagawa K, Harada H, Nagato S, Furukawa K, Teraoka M, Seno T, Oka K, Iwata S, Ohnishi T. Silencing hypoxia-inducible factor-1alpha inhibits cell migration and invasion under hypoxic environment in malignant gliomas. Int J Oncol 2007; 30: 793–802.
- 33 Verbridge SS, Choi NW, Zheng Y, Brooks DJ, Stroock AD, Fischbach C. Oxygen-controlled three-dimensional cultures to analyze tumor angiogenesis. Tissue Eng Part A 2010; 16: 2133–2141.
- 34 Cross VL, Zheng Y, Won Choi N, Verbridge SS, Sutermaster BA, Bonassar LJ, Fischbach C, Stroock AD. Dense type i collagen matrices that support cellular remodeling and microfabrication for studies of tumor angiogenesis and vasculogenesis in vitro. Biomaterials 2010; 31: 8596–8607.
- 35 Nelson CM, Inman JL, Bissell MJ. Three-dimensional lithographically defined organotypic tissue arrays for quantitative analysis of morphogenesis and neoplastic progression. Nat Protoc 2008; 3: 674–678.
- 36 Saltzman W. Tissue Engineering: Principles for the Design of Replacement Organs and Tissues. New York: Oxford University Press; 2004.
- 37 Hong B, Lui VW, Hui EP, Ng MH, Cheng SH, Sung FL, Tsang CM, Tsao SW, Chan AT. Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with chk1/2 activation. Invest New Drugs 2011; 29: 401–410.
- 38 Bertout JA, Patel SA, Simon MC. The impact of o2 availability on human cancer. Nat Rev Cancer 2008; 8: 967–975.
- 39 Lakka SS, Rao JS. Antiangiogenic therapy in brain tumors. Expert Rev Neurother 2008; 8: 1457–1473.
- 40 Lin EH, Hassan M, Li Y, Zhao H, Nooka A, Sorenson E, Xie K, Champlin R, Wu X, Li D. Elevated circulating endothelial progenitor marker cd133 messenger RNA levels predict colon cancer recurrence. Cancer 2007; 110: 534–542.
- 41 Mimeault M, Batra SK. Recent advancements on the identification of immature cancer cells with the stem cell-like properties in different aggressive and recurrent cancer types. Anticancer Agents Med Chem 2010; 10: 103.